- Mithril Capital’s Ajay Royan Talks About Working with Peter Thiel and Why ‘Investing Is Hard’From sealing its largest-ever exit to facing criticisms of its business model, it's been an interesting month for the venture capital firm.
- Johnson & Johnson Will Be The First Drug Company To Put Prescription Medication Prices in TV Ads"We think the education of consumers is a good thing"
- Johnson & Johnson’s Slowdown Signals a Warning to Health Care SectorThe company is the first major medical manufacturer to report earnings for the fourth quarter.
- Johnson & Johnson’s $50 Billion Baby Powder Problem Just Got a Whole Lot Worse. Here’s WhyIndian drug inspectors have taken factory samples of Johnson's Baby Powder for asbestos testing
- Glaxo to Split in Two Following Venture Deal with PfizerThe pharma giants plan to create a consumer-health joint venture and list it on the stock market
- Companies Strike Back, Moonves, China: CEO Daily for December 18, 2018Companies push back against media onslaught.
- Report Claims Johnson & Johnson Knew Baby Powder Contained Asbestos for DecadesDocuments seem to counter long-time company claims.
Skip to Content